BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Son SH, Park J, Jung MJ, Lee SK, Kim H, Kim KR, Park KK, Chung WY. Transforming growth factor-β-regulated fractalkine as a marker of erosive bone invasion in oral squamous cell carcinoma. Eur J Oral Sci 2021;129:e12750. [PMID: 33503283 DOI: 10.1111/eos.12750] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Vanini JV, Koyama LKS, de Matos LL, Junior JMF, Cernea CR, Nagano CP, Coutinho-camillo CM, Hsieh R, Lourenço SV. Epithelial-mesenchymal transition related to bone invasion in oral squamous cell carcinoma. Journal of Bone Oncology 2022. [DOI: 10.1016/j.jbo.2022.100418] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Hwang BO, Park SY, Cho ES, Zhang X, Lee SK, Ahn HJ, Chun KS, Chung WY, Song NY. Platelet CLEC2-Podoplanin Axis as a Promising Target for Oral Cancer Treatment. Front Immunol 2021;12:807600. [PMID: 34987523 DOI: 10.3389/fimmu.2021.807600] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Xu TT, Zeng XW, Wang XH, Yang LX, Luo G, Yu T. Cystatin-B Negatively Regulates the Malignant Characteristics of Oral Squamous Cell Carcinoma Possibly Via the Epithelium Proliferation/Differentiation Program. Front Oncol 2021;11:707066. [PMID: 34504787 DOI: 10.3389/fonc.2021.707066] [Cited by in F6Publishing: 1] [Reference Citation Analysis]